Clinical Trial Update: Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor [Phase 1]

View source ↗

Summary

Completed Phase 1 trial evaluating adaptive 18F-FDG-PET guided Biological Intensity-modulated Radiotherapy (BG-IMRT) in patients with head and neck tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: University Hospital, Ghent | Conditions: Head and Neck Tumor | Phase 1 | Status: COMPLETED